Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousAntineoplastic Combined Chemotherapy ProtocolsWhole-Body IrradiationBone and BonesCombined Modality TherapyTreatment OutcomeHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticCyclophosphamideLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingRecurrenceHematopoietic Stem CellsTime FactorsHistocompatibilitySurvival AnalysisBone Marrow DiseasesTransplantation, IsogeneicRetrospective StudiesPrognosisKidney TransplantationSurvival RateHematopoiesisImmunosuppressive AgentsLeukemia, Myeloid, AcuteFatal OutcomeRadiation ChimeraMice, Inbred C57BLDisease-Free SurvivalFollow-Up StudiesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation DosagePrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow ExaminationAcute DiseaseLymphoma, Non-HodgkinHematologic NeoplasmsChemotherapy, AdjuvantRemission InductionRadiation InjuriesGraft RejectionHepatic Veno-Occlusive DiseaseLeukemia, MyeloidBone RemodelingBone Marrow NeoplasmsStem Cell TransplantationTransplantation ImmunologyRadiation, IonizingAntineoplastic AgentsGraft vs Host ReactionMethotrexateImmunosuppressionEtoposideLymphocyte DepletionHodgkin DiseaseLeukocyte TransfusionHeart TransplantationActuarial AnalysisColony-Forming Units AssayMyelodysplastic SyndromesSevere Combined ImmunodeficiencyT-LymphocytesDose-Response Relationship, RadiationCarmustineHematologic DiseasesCytarabineDoxorubicinChimeraProspective StudiesHLA AntigensLung TransplantationCyclosporineBone DensityGranulocyte Colony-Stimulating FactorLymphocyte TransfusionMelphalanLymphomaLeukocyte CountNuclear FamilyPancytopeniaRisk FactorsRadiationOrgan TransplantationCell DifferentiationGraft vs Tumor EffectNeoplasm Recurrence, LocalGraft vs Leukemia EffectMice, Inbred BALB C